ARTICLES BY THIS AUTHOR
- 11/4/2013
Intuniv XR: first alpha agonist approved for ADHD
Shire Canada is introducing Intuniv XR (guanfacine 1 mg, 2 mg, 3mg, and 4 mg extended-release tablets), the first selective alpha2A-adrenergic receptor agonist to be approved for the treatment of attention deficit hyperactivity disorder (ADHD) in Canada. - 11/4/2013
Nurses’ union cites poor conditions
- 11/4/2013
New option for pancreatic cancer
- 11/3/2013
Pharmacists brush up on self-care counselling skills
More than 170 pharmacists gave up their Sunday to attend an all-day education day focused on helping them become more confident self-care advisors. - 11/3/2013
Despite legal change, Ontario college to uphold ban on treating spouses
TORONTO | The Ontario college says it won’t alter a ban on physicians treating spouses, despite the passing of a private member’s bill that loosens the law for health professionals. - 10/31/2013
Boning up on osteoporosis
- 10/31/2013
Deadlines to complete bridging courses loom in some provinces
Pharmacy assistants working towards regulation through the “in the profession” pathway in Ontario, Alberta, and British Columbia have a limited time to complete the four bridging courses. - 10/31/2013
College of Pharmacists of B.C. works to integrate techs
Regulated technicians in British Columbia now have a stronger voice in the governance of the province’s pharmacy regulatory body.